[Biotech&Pharma] Aldevron Adds DasherGFP® mRNA to its Product Portfolio

Browse By

Fargo, N.D., Feb. 12, 2020 (GLOBE NEWSWIRE) — Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, announced today the addition of DasherGFP (green fluorescent protein) mRNA to its off-the-shelf product portfolio. 

The DasherGFP mRNA encodes an IP-free, fluorescent protein engineered by ATUM, a collaborating partner with Aldevron, for optimal expression in mammalian cells. The expressed protein yields a bright green fluorescence allowing scientists to easily track and analyze mRNA delivery and translation. 

“The biotech industry's use of mRNA to fight disease is growing exponentially and Aldevron is committed to providing our clients the highest quality biologics to …

Full story available on Benzinga.com

Source Benzinga

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.